Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.
about
A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem CellsHuman adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applicationsUse of mesenchymal stem cells for therapy of cardiac diseaseAdvances in cell culture: anchorage dependence.Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expressionCharacteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancerTranscriptional analysis of fracture healing and the induction of embryonic stem cell-related genesThe LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cellsHuman embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterpartsTherapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.Human amniotic fluid stem cells support undifferentiated propagation and pluripotency of human embryonic stem cell without b-FGF in a density dependent manner.Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissuesIntravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth.Genome-wide analysis reveals the unique stem cell identity of human amniocytesSpindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection ProcedureIn utero therapy for congenital disorders using amniotic fluid stem cells.Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cellsCharacterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells.Profilin 1 is a potential biomarker for bladder cancer aggressivenessDevelopment of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in CultureEvaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservationHuman Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis.Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental CellsProteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from Decidua Basalis of Human Term PlacentaReviewing and updating the major molecular markers for stem cellsAF-MSCs fate can be regulated by culture conditionsOsteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes.Novel sources of fetal stem cells: where do they fit on the developmental continuum?Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells.Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer modelsMesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.The potential of amniotic fluid stem cells for cellular therapy and tissue engineering.Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.
P2860
Q26774930-7816096E-BD8F-4084-8997-81FD638B80B1Q26998695-5A5E0952-0C13-4766-81EC-B12DE2326B8EQ27003127-80EA30F5-DBBB-4449-BCAA-43FE9694F5ADQ27015670-D0438C87-A96D-41B2-9FB0-684510DD4B1BQ28533820-7B8A102E-AF1C-48D2-90B0-637C6A3C613DQ28546467-A7D9B0BA-8ED3-42FC-A89D-1F1EFBB15143Q33438889-300ECE07-DC09-4BA1-9AE7-6BBFC5049124Q33741989-205AAFC3-C658-4AF7-B71A-5A934F006B0FQ34023300-9A5FBA8D-A5E7-4297-BF21-10DE9FB9C87DQ34038582-44C2C3CD-0A83-41CD-AFC7-52B16E9463FBQ34121318-F1055589-8487-47EA-9AC2-7F692EAF81EEQ34333323-1030D496-6FA0-4FC1-8BB8-055031D38ADFQ34389750-AAE36C72-0A6D-4CA2-BB9D-BF8FF73FD55BQ34419494-5DB8DBE3-5683-4AD0-8ADF-14AC029B7E6EQ34551352-FAB4A775-B49A-45FE-B4FE-23FBB2775CF2Q34566545-7B3F32F5-ADB4-4FAC-B065-304C808200A9Q34706591-7D88FAB8-28F1-4CDB-9C10-1B90391116FDQ34741419-177F7A41-C982-4B5A-8223-84FD02CD9EDCQ35166506-1F9B7E8B-FEF5-4D32-BB5C-5AD8D8F01D0BQ35200174-BA717324-BB02-40C8-91D0-60B9011CB8ACQ35878733-964E326D-3F48-4879-85A3-1C71AD34BDABQ35925098-AF48E832-F459-4D57-B28A-8C90C7B48325Q35992742-27C086F7-165E-4CB4-8027-59D66BD3B5D8Q36006711-6B45C314-A2E9-4ADB-A0A9-6552A1A00CB3Q36067842-1AB29C59-E410-4B0F-B44B-D3B1677D8888Q36125132-3E997A35-8ADD-4DC5-B601-4214DCC7D06CQ36610567-922DEF61-A080-4A00-A738-7611BAEB0F2FQ36776491-B5BD3200-5677-4AD3-9E74-AAD1822440E5Q36890227-D6B9508E-1F55-4C32-A2E3-7D2313DF03B2Q37366660-6574EC69-E687-4AE9-8D66-E68B89BC7214Q37479813-563E238D-1979-4761-A19B-6CC3DF96181EQ37516478-D9FDCDFF-D24F-49F1-AEA2-2DF9FC10F04AQ37568639-A85A445A-B47C-4DAE-8F90-FCB561B2E88FQ37612793-4FCB2DC8-7CC5-46C8-8A68-B6C9A6F287FFQ37688606-6B5726FC-C910-4477-BDA3-DF2CD0F2769DQ37859370-85904311-E614-455C-8A47-F6589C7D1220Q37881973-86E0C641-B88F-4C0F-BF15-C044EF0BC2F0Q37967561-0E29BA4E-4EE5-4838-AF39-654AC4AFF243Q38014437-5D2FDA92-3134-4530-B3AA-C9BC42912690Q38044182-9F4EF717-6E75-458C-BDBE-202A7B150C3B
P2860
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@ast
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@en
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@nl
type
label
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@ast
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@en
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@nl
prefLabel
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@ast
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@en
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@nl
P2093
P356
P1476
Molecular and proteomic charac ...... marrow mesenchymal stem cells.
@en
P2093
Aristidis Antsaklis
Dimitra Zagoura
Helen A Papadaki
Kalliopi I Pappa
Nicholas P Anagnou
Vasiliki Bitsika
P304
P356
10.1089/SCD.2007.0036
P577
2007-12-01T00:00:00Z